- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | Lifecare ASA: Deutlicher Umsatzrückgang und steigende Verluste im Jahresabschluss | 1 | IT BOLTWISE | ||
| Do | LIFE: Lifecare ASA Q4 2024 | 4 | Oslo Børs | ||
| 14.02. | Lifecare ASA: Financial calendar | 3 | Oslo Børs | ||
| 04.02. | Lifecare ASA: LIFE: Improved chemistry successfully tested in sensor | 4 | Oslo Børs | ||
| 16.01. | Lifecare ASA: Financial calendar | 2 | Oslo Børs | ||
| LIFECARE ASA Aktie jetzt für 0€ handeln | |||||
| 14.01. | Lifecare ASA: LIFE Fivefold improvement of sensor chemistry sensitivity | 5 | Oslo Børs | ||
| 13.11.24 | LIFE: Lifecare ASA Q3 2024 | 3 | Oslo Børs | ||
| 05.11.24 | Lifecare ASA Q3 2024 presentation | 3 | Oslo Børs | ||
| 29.10.24 | Lifecare ASA: Lifecare - Sanofi Product Development Agreement Update | 22 | Oslo Børs | ||
| 22.10.24 | Lifecare ASA listed on Euronext Oslo Børs | 2 | Oslo Børs | ||
| 21.10.24 | Nasdaq Stockholm AB: Admission to trading of Lifecare ASA on First North NOK | 234 | GlobeNewswire | Nasdaq Stockholm AB has admitted Lifecare ASA shares to trading on First North
NOK, with effect from October 22, 2024.
The shares will be traded on the First North NOK segment.
Short name: LIFEo... ► Artikel lesen | |
| 21.10.24 | LIFE Lifecare ASA uplisting to Euronext Oslo Børs is approved | 1 | Oslo Børs | ||
| 18.10.24 | Lifecare ASA: Share capital increase registered | 1 | Oslo Børs | ||
| 15.10.24 | Lifecare ASA: Last day of application period | 1 | Oslo Børs | ||
| 14.10.24 | Lifecare ASA: Lifecare presentation at the Diabetes Technology Meeting 2024. | 2 | Oslo Børs | ||
| 14.10.24 | Lifecare ASA: Application deadline for applicants using Nordnet webservice | 3 | Oslo Børs | ||
| 10.10.24 | Lifecare ASA: Mandatory notification of trade | 1 | Oslo Børs | ||
| 10.10.24 | Lifecare ASA: LIFE Study protocol has been finalized for submission to regulatory authorities | 1 | Oslo Børs | ||
| 08.10.24 | Lifecare ASA: Launch of public retail offering and commencement of application period | 1 | Oslo Børs | ||
| 08.10.24 | Lifecare ASA: LIFE Longevity trial: Biopsy and bacteriological examination confirm no unexpected foreign body reactions after removal of implant | 2 | Oslo Børs |
Seite:
1 2 Weiter >>
40 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ROKU | 84,89 | -0,09 % | Streaming-Revolution?: Roku-Rallye: Analysten heben Kursziele drastisch an! | © Foto: Pavlo Gonchar - picture allianceDie Kursziele von Roku wurden angehoben, da Analysten großes Wachstumspotenzial sehen - steckt hier die nächste große Investmentchance?Die Aktie von Roku verzeichnete... ► Artikel lesen | |
| SERNOVA BIOTHERAPEUTICS | 0,131 | -1,80 % | XETR NEW INSTRUMENTS AVAILABLE ON XETRA - 13.02.2025 | Das Instrument PSH0 CA81752F1062 SERNOVA BIOTHERAPEUTICS EQUITY hat seinen ersten Handelstag am 13.02.2025: CONTINUOUS TRADING WITH AUCTIONS, PAG NAM0, SettlCurr EUR, CCP Y
The instrument PSH0 CA81752F1062... ► Artikel lesen | |
| BOSTON SCIENTIFIC | 100,00 | 0,00 % | Boston Scientific's American Medical Systems Europe Prices EUR 1.5 Bln Of Senior Notes | WASHINGTON (dpa-AFX) - Boston Scientific Corp. (BSX) announced that American Medical Systems Europe B.V., its wholly owned finance subsidiary, has priced a public offering of 850 million euros... ► Artikel lesen | |
| PAUL HARTMANN | 240,00 | +0,42 % | Vorläufiges Jahresergebnis 2024: PAUL HARTMANN steigert Ergebnis gegenüber dem Vorjahr deutlich und strebt für 2025 weitere Verbesserung an | Heidenheim (ots) - HARTMANN hat im vergangenen Jahr sein Transformationsprogramm erfolgreich weitergeführt. Es trug zu deutlichen Verbesserungen im Ergebnis bei, trotz konstant herausfordernder Marktlage.... ► Artikel lesen | |
| ADDLIFE | 14,890 | -1,06 % | AddLife AB: Year-end Report 1 January - 31 December 2024 | AddLife finishes the year with high growth, improved margins, and strong cash flow
"AddLife finishes 2024 with a very strong fourth quarter. Organic growth was 9%, EBITA increased by 24%, and cash... ► Artikel lesen | |
| EMBECTA | 13,700 | 0,00 % | Embecta Corp. Reports First Quarter Fiscal 2025 Financial Results | PARSIPPANY, N.J., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta" or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three month... ► Artikel lesen | |
| R1 RCM | 13,400 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 19.11.2024 | The following instruments on Boerse Frankfurt do have their last trading day on 19.11.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 19.11.2024ISIN NameAU000000SVW5 SEVEN... ► Artikel lesen | |
| ENOVIS | 41,000 | 0,00 % | Enovis Corporation: Enovis Announces Leadership Change to International Surgical Business | Wilmington, DE, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Enovis, a global medical technology innovator headquartered in the United States, announced recently that Davide Visentin will succeed Dr. Benjamin... ► Artikel lesen | |
| SYSMEX | 17,000 | 0,00 % | Dividendenbekanntmachungen (27.09.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABRDN EUROPEAN LOGISTICS INCOME PLC GB00BD9PXH49 0,0077 GBP EUR ACADIAN TIMBER CORP CA0042721005 0,29 CAD 0,1926 EUR ACOM CO LTD JP3108600002 7... ► Artikel lesen | |
| PULMONX | 7,850 | -8,72 % | Pulmonx Corporation: Pulmonx Reports Record Fourth Quarter and Full Year 2024 Financial Results | REDWOOD CITY, Calif., Feb. 19, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) ("Pulmonx" or the "Company"), a global leader in minimally invasive treatments for lung disease, today reported... ► Artikel lesen | |
| KANGJI MEDICAL | 0,915 | +16,56 % | HSI Closes at 23,341, Down 136 pts; HSTI Closes at 5,789, Down 69 pts; TENCENT Down over 3%; SMIC, YIXIN, LEGENDHOLDING, JF SMARTINVEST, KANGJI MEDICAL Hit New Highs; Market Turnover Rises | ||
| SI-BONE | 16,800 | -1,75 % | SI-BONE, Inc.: SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2024 | Fourth Quarter 2024 worldwide revenue of ~$48.8 to $49.0 million representing growth of ~26%Achieved adjusted EBITDA profitability in the fourth quarter SANTA CLARA, Calif., Jan. 13, 2025 (GLOBE NEWSWIRE)... ► Artikel lesen | |
| KOOTH | 1,800 | 0,00 % | TRADING UPDATES: Kooth eyes top-end profit, while IQE sees sales beat | ||
| REVITALIST LIFESTYLE AND WELLNESS | 0,015 | -100,00 % | Revitalist Lifestyle & Wellness Ltd: Revitalist Announces Filing of Audited Financial Statements for the Year-Ended December 31, 2022 and Provides Update on Cease Trade Order | Vancouver, British Columbia--(Newsfile Corp. - February 18, 2025) - Revitalist Lifestyle and Wellness Ltd. (CSE: CALM) (OTCQB: RVLWF) (FSE: 4DO) (the "Company") wishes to announce that, further to... ► Artikel lesen |
LIFECARE ASA gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 1,035 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu LIFECARE ASA finden Sie auf Wallstreet Online.
